文献速递肝病

儿童非酒精性脂肪性肝病的独特考量与挑战

Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
PubMed 文献 · Gastroenterology · 2020-03-20

儿童非酒精性脂肪性肝病(NAFLD)随全球肥胖流行而患病率上升且诊断年龄提前。儿童在组织学特征和早期表现上的独特性提示其发病机制可能与成人不同,对遗传和环境因素更易感;宫内及围产期应激可能改变终身健康轨迹,增加NAFLD及心血管代谢疾病风险。儿童期发病和进展可能带来长期发病率风险,亟需新型生物标志物和治疗药物。

要点

  • 儿童NAFLD患病率随肥胖流行上升,诊断年龄提前。
  • 儿童对遗传和环境因素更易感,宫内及围产期应激影响终身健康。
  • 儿童期发病进展增加长期 morbidity 风险,需新型生物标志物和治疗药物。

核心结论

  • 儿童NAFLD的独特组织学特征和早期表现提示儿童与成人发病机制可能不同。
  • 儿童期发病和进展可能增加长期 morbidity 风险,需新型生物标志物和治疗药物。

主要发现

  • 儿童NAFLD患病率随全球肥胖流行而增加,诊断年龄越来越小。
  • 儿童对遗传和环境因素更易感。
  • 宫内及围产期应激可能改变儿童终身健康轨迹,增加NAFLD和其他心血管代谢疾病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence in concert with the global epidemic of obesity and is being diagnosed at increasingly younger ages. The unique histologic features and early presentation of disease in pediatrics suggest that children and adults may differ with regard to etiopathogenesis, with children displaying a greater vulnerability to genetic and environmental factors. Of significant relevance to pediatrics, in utero and perinatal stressors may alter the lifelong health trajectory of a child, increasing the risk of NAFLD and other cardiometabolic diseases. The development and progression of disease in childhood is likely to carry increased risk of long-term morbidity. Novel biomarkers and therapeutic agents are needed to avoid the otherwise inevitable health and societal consequences of this rapidly expanding pediatric population.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Goldner D, Lavine JE. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. Gastroenterology. 2020. PMID: 32201176. doi:10.1053/j.gastro.2020.01.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。